NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/01/2025
Back to search
Official data from USPTO
ALLOPLY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
04/01/2025
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
06/30/2023
Registration date
04/01/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/01/2025
Last transaction
04/01/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2024-11-00
First use in commerce
2024-11-00
Drawing code
3
Owner type
16
Owner location
San Antonio, TX, US
Examiner
OH, HYUN-JUNG
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of The literal element ALLOPLY in stylized font to the right of a design element having three curved and separated bands partially surrounding the letters AL.
Holders and representatives
Holders
Bio Creations Medical, LLC
Representatives
Ryan D. Artis RIVERSIDE LAW
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological tissuetissue for wound care and surgical use; Implants comprising living tissue; Biological tissue grafts; Human allograft tissue; Cells for medical or clinical use
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/01/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/08/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/08/2025
DOCK
ASSIGNED TO EXAMINER
02/18/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/17/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/16/2025
IUAF
USE AMENDMENT FILED
12/04/2024
EISU
TEAS STATEMENT OF USE RECEIVED
12/04/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2024
PUBO
PUBLISHED FOR OPPOSITION
04/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/20/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/07/2024
DOCK
ASSIGNED TO EXAMINER
02/29/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/01/2023
NWAP
NEW APPLICATION ENTERED
07/04/2023
Continuous trademark protection
Get notified about every new filing that threatens ALLOPLY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.